Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,477 | -14,732 | -10,925 | -12,350 | -4,622 |
| Depreciation Amortization | 54 | 87 | 69 | 71 | N/A |
| Income taxes - deferred | 189 | 191 | 191 | -1 | N/A |
| Accounts payable and accrued liabilities | -652 | -738 | -132 | 220 | 343 |
| Other Working Capital | -177 | -539 | -243 | -581 | 1,580 |
| Other Operating Activity | 19,081 | 7,024 | 6,357 | 3,850 | 39 |
| Operating Cash Flow | $-11,982 | $-8,709 | $-4,683 | $-8,791 | $-2,659 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | N/A | 3,762 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $3,762 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | 3,000 | 3,000 | 15,323 | N/A |
| Common Stock Issued | 4,252 | 4,252 | 4,372 | 1,382 | 1,382 |
| Financing Cash Flow | $7,252 | $7,252 | $7,372 | $16,705 | $1,382 |
| Exchange Rate Effect | 8 | 11 | 1 | -145 | N/A |
| Beginning Cash Position | 14,848 | 14,848 | 14,848 | 3,317 | 3,317 |
| End Cash Position | 10,127 | 13,403 | 17,539 | 14,848 | 2,040 |
| Net Cash Flow | $-4,729 | $-1,445 | $2,690 | $11,531 | $-1,277 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,982 | -8,709 | -4,683 | -8,791 | -2,659 |
| Free Cash Flow | -11,982 | -8,709 | -4,683 | -8,791 | -2,659 |